Vericel Corp Ord (VCEL) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $37.68
• Market Cap: $1.88B
• P/E Ratio: 142.65
• EPS: $0.26
• 52-Week High: $52.06
• 52-Week Low: $29.24

Market Sentiment

Vericel Corp Ord currently has a Bullish sentiment score of 0.47.

About Vericel Corp Ord

Vericel Corporation (VCEL) is a leading commercial-stage biopharmaceutical company focused on innovative cell therapies for the sports medicine and severe burn care sectors in the United States. Headquartered in Cambridge, Massachusetts, Vericel is dedicated to advancing the treatment options for patients through its proprietary products, including MACI® and Epicel®. With a robust commitment to research and development, the company aims to enhance patient outcomes and address unmet medical ne...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Vericel Corp Ord and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does VCEL pay dividends?

Vericel Corp Ord (VCEL) does not currently pay a regular dividend.

What is VCEL's P/E ratio?

Vericel Corp Ord has a price-to-earnings (P/E) ratio of 142.65.

What is VCEL's market cap?

Vericel Corp Ord (VCEL) has a market capitalization of $1.88B with a current stock price of $37.68.